Feng-hou Gao
Shanghai, 200336, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Genomic characteristics of sequence type 80 of Campylobacter fetus subsp. testudinum from bacteremia
Genomic characteristics of sequence type 80 of Campylobacter fetus subsp. testudinum from bacteremia
Journal: Zhonghua yi xue za zhi
Published: June 08, 2025
Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma.
Journal: Cancer biology & therapy
Published: August 01, 2024
Isoalantolactone mediates the degradation of BCR-ABL protein in imatinib-resistant CML cells by down-regulating survivin.
Journal: Cell cycle (Georgetown, Tex.)
Published: May 19, 2023
Tumor microenvironment immune-related lncRNA signature for patients with melanoma.
Journal: Annals of translational medicine
Published: June 24, 2021
Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10.
Journal: Frontiers in immunology
Published: March 24, 2020
MicroRNA-92b acts as an oncogene by targeting PTEN/AKT in NSCLC.
Journal: Cell biochemistry and function
Published: September 01, 2019
Oridonin induces Mdm2-p60 to promote p53-mediated apoptosis and cell cycle arrest in neuroblastoma.
Journal: Cancer medicine
Published: January 08, 2019
Th17 Cells Paradoxical Roles in Melanoma and Potential Application in Immunotherapy.
Journal: Frontiers in immunology
Published: November 20, 2018
Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation.
Journal: Journal of Cancer
Published: August 27, 2018
GSK3β-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1 arrest in neuroblastoma cells.
Journal: Cell cycle (Georgetown, Tex.)
Published: October 06, 2017
The Molecular Mechanisms of Regulation on USP2's Alternative Splicing and the Significance of Its Products.
Journal: International journal of biological sciences
Published: June 20, 2017
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia.
Journal: Nature communications
Published: January 15, 2017
Last Updated: 09/26/2026